Aarti Drugs

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE767A01016
  • NSEID: AARTIDRUGS
  • BSEID: 524348
INR
484.55
-14.8 (-2.96%)
BSENSE

Nov 20

BSE+NSE Vol: 3.13 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 657348,
    "name": "Aarti Drugs",
    "stock_name": "Aarti Drugs",
    "full_name": "Aarti Drugs Ltd",
    "name_url": "stocks-analysis/aarti-drugs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "484.55",
    "chg": -14.8,
    "chgp": "-2.96%",
    "dir": -1,
    "prev_price": "499.35",
    "mcapval": "4,535.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524348,
    "symbol": "AARTIDRUGS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE767A01016",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "3.13 lacs",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/aarti-drugs-657348-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Aarti Drugs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-buy-by-marketsmojo-4269247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AartiDrugsLtd_mojoScore_4269247.png",
        "date": "2026-11-20 10:10:35",
        "description": "Aarti Drugs Ltd is rated Buy by MarketsMOJO, with this rating last updated on 04 Nov 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 20 November 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Aarti Drugs Gains 13.66%: 2 Key Factors Driving the Surge",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-gains-1366-2-key-factors-driving-the-surge-4261952",
        "imagepath": "",
        "date": "2026-11-14 16:02:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 9:</strong> Intraday high of Rs.486.25 with a 7.73% surge</p>\n                    <p><strong>Nov 11:</strong> Minor correction to Rs.491.90 (-1.68%)</p>\n                    <p><strong>Nov 12:</strong> Recovery with 3.57% gain to Rs.509.45</p>\n                    <p><strong>Nov 13:</strong> New 52-week high of Rs.527.85, closing at Rs.507.55 (-0.37%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.446.55</div>\n                    </div>\n                    <div class=\"stat-item\">\n                      ..."
      },
      {
        "title": "Aarti Drugs Ltd is Rated Buy by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/aarti-drugs-ltd-is-rated-buy-by-marketsmojo-4256745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AartiDrugsLtd_mojoScore_4256745.png",
        "date": "2026-11-09 10:10:22",
        "description": "Aarti Drugs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 04 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Aarti Drugs Ltd Surges 7.73% to Day's High of Rs 486.25 — Outperforms Sector by 5.76 Percentage Points",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-ltd-hits-intraday-high-with-773-surge-on-9-nov-2026-4256518",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AartiDrugsLtd_priceRelatedfactors_4256518.png",
        "date": "2026-11-09 09:56:35",
        "description": "The Sensex declined 0.24% on 09 Nov 2026 while Aarti Drugs Ltd surged 7.73%, marking a standout session with a 5.76 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers. The stock touched an intraday high of Rs 486.25, rewriting the short-term narrative amid a broadly weak market backdrop."
      },
      {
        "title": "Aarti Drugs Gains 2.49%: 3 Key Factors Driving the Week’s Momentum",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-gains-249-3-key-factors-driving-the-weeks-momentum-4255639",
        "imagepath": "",
        "date": "2026-11-07 16:05:23",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 2:</strong> Stock surges 4.15% on strong volume</p>\n                    <p><strong>Nov 3:</strong> Continued gains lift price to Rs.465.60 (+2.60%)</p>\n                    <p><strong>Nov 4:</strong> Reports strong quarterly performance; technical momentum shifts bullish</p>\n                    <p><strong>Nov 5:</strong> Stock dips 2.23% despite Sensex rally</p>\n                    <p><strong>Nov 6:</strong> Modest recovery with 0.51% gain; closes week at Rs.446.55</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.435.70</div></div>\n                    ..."
      },
      {
        "title": "Aarti Drugs Ltd Reports Strong Quarterly Performance, Upgrades Financial Trend to Positive",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-ltd-reports-strong-quarterly-performance-upgrades-financial-trend-to-positive-4250731",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AartiDrugsLtd_fintrenddot_4250731.png",
        "date": "2026-11-04 11:00:25",
        "description": "Aarti Drugs Ltd has demonstrated a marked improvement in its financial performance for the quarter ended September 2026, prompting an upgrade in its mojo grade from Hold to Buy. The pharmaceutical company posted record quarterly revenues and profitability metrics, signalling a positive shift in its financial trend after a period of stagnation."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts to Bullish Amid Strong Price Gains",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-to-bullish-amid-strong-price-gains-4249872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/AartiDrugsLtd_technicaldot_4249872.png",
        "date": "2026-11-04 08:03:31",
        "description": "Aarti Drugs Ltd has witnessed a notable shift in its technical momentum, upgrading from a mildly bullish to a bullish stance. This change is underpinned by a confluence of positive signals across key indicators such as MACD, moving averages, and Bollinger Bands, suggesting an improving price trajectory for this small-cap pharmaceutical stock."
      },
      {
        "title": "Aarti Drugs Surges 16.50%: 3 Key Factors Driving This Week’s Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-surges-1650-3-key-factors-driving-this-weeks-rally-4245984",
        "imagepath": "",
        "date": "2026-10-31 16:04:09",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>26 Oct:</strong> Stock opens week at ₹379.70, up 1.52%</p>\n                    <p><strong>27 Oct:</strong> Upgraded to Hold as technicals improve; closes at ₹403.40 (+6.24%)</p>\n                    <p><strong>28 Oct:</strong> Hits intraday high of ₹454 with 9.97% surge</p>\n                    <p><strong>30 Oct:</strong> Week closes at ₹435.70, down 2.95% on the day but up 16.50% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.374.00</div>\n                    </div>\n                    <div cl..."
      },
      {
        "title": "Aarti Drugs Ltd Technical Momentum Shifts Signal Mildly Bullish Outlook",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/aarti-drugs-ltd-technical-momentum-shifts-signal-mildly-bullish-outlook-4240028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/AartiDrugsLtd_technicaldot_4240028.png",
        "date": "2026-10-27 08:03:51",
        "description": "Aarti Drugs Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance, supported by mixed signals from key indicators such as MACD, RSI, and moving averages. This transition, coupled with a recent upgrade in its Mojo Grade from Sell to Hold, suggests cautious optimism for investors amid a challenging market backdrop."
      }
    ],
    "total": 71,
    "sid": "657348",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/aarti-drugs-657348"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Demise",
      "datetime": "15-Nov-2026",
      "details": "Intimation of sad demise of Promoter and Chairman Emeritus of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "10-Nov-2026",
      "details": "Transcript of Q2&H1 FY27 Earning Conference call",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "06-Nov-2026",
      "details": "Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations 2015",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has declared <strong>20%</strong> dividend, ex-date: 09 Feb 26",
          "dt": "2026-02-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Aarti Drugs Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 30 Sep 20",
          "dt": "2020-09-30",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Demise

15-Nov-2026 | Source : BSE

Intimation of sad demise of Promoter and Chairman Emeritus of the Company

Announcement under Regulation 30 (LODR)-Earnings Call Transcript

10-Nov-2026 | Source : BSE

Transcript of Q2&H1 FY27 Earning Conference call

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

06-Nov-2026 | Source : BSE

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requireents) Regulations 2015

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Aarti Drugs Ltd has declared 20% dividend, ex-date: 09 Feb 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Aarti Drugs Ltd has announced 3:1 bonus issue, ex-date: 30 Sep 20

stock-summary
RIGHTS

No Rights history available